Market Overview

Benzinga's Top Pre-Market Gainers

Related NVAX
Novavax Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP
Events for the Week of Nov. 17-21, 2014
Related VLTR
Maxim Extends Tender Offer for Outstanding Shares of Volterra Semiconductor to October 1, 2013
New Companies Make Most Attractive/Dangerous Lists

Novavax (NASDAQ: NVAX) moved up 16.33% to $2.92 in the pre-market session. Novmax's trailing-twelve-month revenue is $17.70 million.

Volterra Semiconductor (NASDAQ: VLTR) soared 8.24% to $16.02 in the pre-market trading after the company agreed to be acquired by Maxim Integrated (NASDAQ: MXIM) for $23 per share.

Agilent Technologies (NYSE: A) surged 4.17% to $48.45 in the pre-market session after the company reported upbeat FQ3 profit and lifted its net income outlook for the fiscal year.

NetEase (NASDAQ: NTES) shares gained 3.50% to $63.60 in the pre-market session after the company reported unaudited Q2 results.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (MXIM + A)

Around the Web, We're Loving...

Get Benzinga's Newsletters